Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Competition lowers the costs of medicines for consumers

Article Abstract:

Limiting government intervention in pharmaceutical pricing enables companies to compete and eventually lower the prices of pharmaceutical preparations. A study of empirical pricing in Denmark, US, Germany, the Netherlands, South Africa and the UK shows that allowing customers to have free access to pharmaceuical markets has a considerable economic advantage. This advantage will be lost if the government will impose regulations that will limit access in favor of safety and efficacy.

Author: Reekie, W. Duncan
Publisher: Economist Newspaper Ltd.
Publication Name: The Economist (UK)
Subject: Business, international
ISSN: 0013-0613
Year: 1997
Administration of General Economic Programs, Price & Wage Controls, Competition (Economics), Laws, regulations and rules, Pricing, Price control, Price regulations, Wage price policy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Balms for the poor

Article Abstract:

There is a need for new drugs to treat illnesses that affect the poor, but pharmaceutical companies tend to focus on drugs that affect people in rich countries. The companies have little incentive to tackle the health problems of people who cannot afford to buy drugs. Health problems can hamper economic development. Public and private sector alliances are one way of tackling this problem. The Medicines for Malaria Venture is an exampleof such cooperation.

Publisher: Economist Newspaper Ltd.
Publication Name: The Economist (UK)
Subject: Business, international
ISSN: 0013-0613
Year: 1999
Health Care and Social Assistance, HEALTH SERVICES, Public Health Care, Health aspects, Developing countries, Public health

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Health check

Article Abstract:

Trends in the pharmaceutical industry are examined in detail, with a focus on the US. Competition from generic drugs, and other factors may prove problematic, but there are also encouraging trends in this sector.

Publisher: Economist Newspaper Ltd.
Publication Name: The Economist (UK)
Subject: Business, international
ISSN: 0013-0613
Year: 2001
Industry Overview, Health care industry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Economic aspects, Pharmaceutical industry, Drugs
Similar abstracts:
  • Abstracts: Large domestic appliances in the UK. Domestic appliances and consumer electronics in Germany. Domestic appliances in France
  • Abstracts: Weirton, where free trade hurts. In America's fiery furnace. Meltdown
  • Abstracts: The masochists' derby. The battle for the Tory party. Yellow in peril
  • Abstracts: Globalstar halts payments on debts to conserve cash. Global TeleSystems to skip payments due on two bonds. MCI strikes deal with two groups of its creditors
  • Abstracts: Asian exporters face gloom. Makeover tip from Korea
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.